Patents by Inventor Antoine Carpentier

Antoine Carpentier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immunostimulatory compositions
    Patent number: 11904014
    Abstract: The invention relates to the use of melanin, complexed with an antigen, as a immunostimulatory composition.
    Type: Grant
    Filed: November 4, 2020
    Date of Patent: February 20, 2024
    Assignees: ASSISTANCE PUBLIQUE—HOPITAUX DE PARIS, UNIVERSITÉ Paris 13
    Inventors: Antoine Carpentier, Claire Banissi
  • OPTIMIZATION OF PEPTIDE-MELANIN BINDING
    Publication number: 20230084978
    Abstract: The invention relates to the use of melanin, complexed with a peptide, in particular containing epitopes for use as an immunostimulatory composition, wherein the peptide that has been modified as to increase nucleophilicity.
    Type: Application
    Filed: February 17, 2021
    Publication date: March 16, 2023
    Inventors: Antoine CARPENTIER, Claire BANISSI
  • IMMUNOSTIMULATORY COMPOSITIONS
    Publication number: 20210060156
    Abstract: The invention relates to the use of melanin, complexed with an antigen, as a immunostimulatory composition.
    Type: Application
    Filed: November 4, 2020
    Publication date: March 4, 2021
    Inventors: Antoine CARPENTIER, Claire BANISSI
  • Immunostimulatory compositions
    Patent number: 10857227
    Abstract: The invention relates to the use of melanin, complexed with an antigen, as a immunostimulatory composition.
    Type: Grant
    Filed: November 25, 2016
    Date of Patent: December 8, 2020
    Assignees: ASSISTANCE PUBLIQUE—HOSPITAUX DE PARIS, UNIVERSITË PARIS 13
    Inventors: Antoine Carpentier, Claire Banissi
  • COMBINATION THERAPY WITH CPG TLR9 LIGAND
    Publication number: 20190134190
    Abstract: The present invention generally relates to an immunostimulatory combination comprising a first composition comprising a therapeutic vaccine and a second composition comprising one or more TLR9 ligand(s) such as CpG-containing oligonucleotide(s) as well as the use of such a first composition in combination with said second composition for treating a subject in need thereof. A specific embodiment is directed to the combination of a vectorized therapeutic vaccine encoding antigen(s) and a CpG-containing oligonucleotide such as Litenimod. Embodiments also include kits comprising such compositions as well as methods for treating, preventing or inhibiting diseases, in particular proliferative diseases or infectious diseases comprising administration of such first and second compositions.
    Type: Application
    Filed: May 3, 2017
    Publication date: May 9, 2019
    Applicants: Transgene SA, Oligovax
    Inventors: Karola Rittner, Roland Kratzer, Antoine Carpentier
  • IMMUNOSTIMULATORY COMPOSITIONS
    Publication number: 20180333483
    Abstract: The invention relates to the use of melanin, complexed with an antigen, as a immunostimulatory composition.
    Type: Application
    Filed: November 25, 2016
    Publication date: November 22, 2018
    Inventors: Antoine CARPENTIER, Claire BANISSI
  • AGENTS FOR THE TREATMENT OF TUMORS
    Publication number: 20140120088
    Abstract: The invention relates to the treatment of patients with a brain tumor or neoplastic meningitis, by the use of an agonist of the TLR9 receptor in combination with an anti-angiogenic product.
    Type: Application
    Filed: May 24, 2012
    Publication date: May 1, 2014
    Applicant: Assistance Publique-Hopitaux de Paris
    Inventor: Antoine Carpentier